摘要
目的:为抗抑郁药临床合理使用提供参考。方法:采用世界卫生组织推荐的限定日剂量(DDD)分析法,对南京地区34家医院2011-2014年抗抑郁药的主要品种、销售金额、用药频度(DDDs)和日均费用(DDC)等进行统计分析。结果:南京地区34家医院2011-2014年抗抑郁药的销售金额和DDDs呈逐年上升趋势,年平均增长率分别为18.21%和19.25%。帕罗西丁、舍曲林各年度DDDs分别列第1、2位;托莫西汀、曲唑酮和度洛西汀各年度DDC均列前3位;帕罗西汀、舍曲林、文法拉辛和艾司西酞普兰各年度销售金额均列前4位;帕罗西汀、米氮平、西肽普兰等的销售金额与DDDs的同步性较好,序号比接近或等于1.00。结论:南京地区34家医院抗抑郁药的临床使用结构和层次较为合理,选择性5-羟色胺(5-HT)再摄取抑制剂和选择性5-HT和去甲肾上腺素再摄取抑制剂两类药物的应用占主导地位;新型抗抑郁药的使用也日益广泛,发展前景广阔。
OBJECTIVE:To provide reference for rational use of antidepressant drugs in the clinic. METHODS:By DDD analysis recommended by WHO,the utilization of antidepressant drugs in 34 hospital from Nanjing area during 2011-2014 were analyzed statistically in respects of main type,consumption sum,DDDs and DDC,etc. RESULTS:The consumption sum and DDDs of antidepressants were increased year by year in 34 hospital from Nanjing area during 2011-2014,with the average annual growth rate of 18.21% and 19.25% respectively. The top 2 drugs by DDDs were paroxetine and setraline;DDC of tomoxetine,trazodone and dutoxetine took up the first 3 place;consumption sum of paroxetine,setraline,venlafaxine and escitalopram took up the first 4places;consumption sum of paroxetine,mirtazapine and citalopram synchronized with their DDDs,and serial number ratio was close to or equal to 1.00. CONCLUSIONS:The use of antidepressant drugs in 34 hospitals from Nanjing area is rational in structure and level;selective 5-hydroxytryptamine(5-HT)reuptake inhibitors(SSRI)and selective 5-HT noradrenaline reuptake inhibitor(SNRI)take up the predominant place;new type of antidepressant drugs are used widely and of great use potentiality in the future.
出处
《中国药房》
CAS
北大核心
2016年第17期2326-2328,共3页
China Pharmacy